ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Flood Asks ACCC for Greater Community Effort

February 14, 1975

In Brief: Thomas Davis, Stanford Oncologist, Dead At 49; DeVita To Visit, NCI; Hunter Named WHI Liaison

September 4, 1992

LeMaistre To Retire As M.D. Anderson President In 1996

August 18, 1995

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

December 4, 1981

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

ACCC Seeks Greater Role In Clinical Research Priorities; Suggests Up To 400 Cancer Program

April 13, 1979